1 – 10 of 10
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis : unpredictable, but predictive of renal outcome
(
- Contribution to journal › Article
- 2017
-
Mark
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
(
- Contribution to journal › Article
- 2016
-
Mark
ANCA-associated glomerulonephritis : Risk factors for renal relapse
(
- Contribution to journal › Article
- 2014
-
Mark
Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis.
(
- Contribution to journal › Article
- 2012
-
Mark
Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
- 2011
-
Mark
Long-term patient survival in ANCA-associated vasculitis
(
- Contribution to journal › Article
- 2009
-
Mark
Optimizing the Birmingham vasculitis activity scale to predict end-stage renal disease and death in ANCA-associated vasculitis
(
- Contribution to journal › Published meeting abstract
-
Mark
The association between relapses of ANCA-associated vasculitis and the composite endpoint of end-stage renal disease or death
(
- Contribution to journal › Published meeting abstract
-
Mark
Predictors of long-term (>= 5 year) renal survival in 535 patients with ANCA-associated vasculitis
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term survival of ANCA-associated vasculitis
(
- Contribution to journal › Published meeting abstract